| 摘要 |
<p>The present invention provides an isolated polypeptide comprising at least one antigenic determinant of Equine Rhinitis A virus (ERAV) VP1. The polypeptide consists of at least 17 and less than 240 amino acids and preferably comprises at least one sequence selected from the group consisting of amino acids 1 to 23, 172 to 188 and 230 to 246 of the amino acid sequence shown as SEQ ID. No. 1.</p> |
